SYSTEM AND METHOD FOR DIAGNOSING AND TREATING LONG QT SYNDROME

• US 20080255464A1
• Filed: 04/10/2007
• Published: 10/16/2008
• Est. Priority Date: 04/10/2007
• Status: Abandoned Application

• Current Assignee: Intellectual Asset Management
• Original Assignee: Intellectual Asset Management
• Inventors: Vincent, G. Michael
• Application Number:
  US11/733,617
• Publication Number:
  US 20080255464A1
• Time in Patent Office: Days
• US Class Current: 600/514
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 7/00 Instruments for auscultation

Abstract

A system for diagnosing Long QT Syndrome (LQTS) derives a QT/QS2 ratio from an electrical systole (QT) and a mechanical systole (QS2) to detect a prolonged QT interval in a patient'"'"'s cardiac cycle. A processor acquires the systoles from a microphone and chest electrodes, calculates the QT/QS2 ratio, and outputs the result to a display. The processor may compare the QT/QS2 ratio to a threshold value stored in memory for diagnosing LQTS in the patient. A user interface provides for programming, set-up, and customizing the display. A mode selector allows the system to operate alternatively as a phonocardiograph, a 12 lead electrocardiograph, or a machine for diagnosing LQTS. A related method for diagnosing cardiac disorders such as LQTS includes measuring QT and QS2 during a same cardiac cycle, calculating a QT/QS2 ratio, and comparing the result to a threshold value derived from empirical data. The method may include measuring systoles both at rest and during exercise, and may be used for drug efficacy, dosage optimization, and acquired LQTS causality tests.

Claims

1. A system for diagnosing LQTS in a patient, comprising:

electrodes for detecting an electrical systole, QT, in the patient;

at least one microphone for detecting a mechanical systole, QS2, in the patient;

a processing module receiving the detected electrical systole and the detected mechanical systole, calculating a QT/QS2 ratio, and outputting the ratio as a diagnostic result.

2. The system of claim 1 further comprising a display unit coupled to the processing module for displaying the QT/QS2 ratio.

3. The system of claim 2 wherein the display unit displays a first waveform representing the electrical systole and a second waveform representing the mechanical systole.

4. The system of claim 1 further comprising a mode selector for selecting between first and second operating modes of the processing module, the processing module in the first operating mode operating as an electrocardiograph, the processing module in the second operating mode calculating the QT/QS2 ratio.

5. The system of claim 1 wherein the electrodes comprise a minimum of ECG leads II, V2 and V3.

6. The system of claim 1 further comprising a user interface coupled to the processing module.

7. The system of claim 1 wherein the processing module further comprises an analog-to-digital converter receiving analog input from the electrodes and the at least one microphone.

8. The system of claim 7 wherein the processing module further comprises a signal conditioning module receiving digital output from the analog-to-digital converter.

9. The system of claim 8 wherein the processing module further comprises a microprocessor coupled to memory.

10. The system of claim 9 wherein the microprocessor calculates the QT/QS2 ratio based on output from the signal conditioning module.

11. The system of claim 10 wherein the microprocessor calculates the QT/QS2 ratio by executing an algorithm stored in the memory.

12. The system of claim 10 wherein the microprocessor compares the QT/QS2 ratio to a threshold value stored in the memory.

13. The system of claim 12 wherein if the QT/QS2 ratio exceeds the threshold value, the microprocessor outputs an alarm.

14. The system of claim 13 further comprising a display unit, wherein the microprocessor outputs the alarm to the display unit.

15. The system of claim 1 wherein the detected electrical systole and the detected mechanical systole received by the processor for calculating the QT/QS2 ratio occur during a same cardiac cycle.

16. The system of claim 1 wherein the electrical systole comprises a time interval during one period of a cardiac cycle from onset of electrical depolarization of heart ventricles to end of electrical repolarization of the heart ventricles.

17. The system of claim 1 wherein the mechanical systole comprises a time interval during one period of a cardiac cycle from onset of electrical depolarization of heart ventricles to occurrence of second heart sound S2.

18. A module for diagnosing LQTS in a patient, comprising:

electrode inputs for receiving electrode signals;

at least one microphone input for receiving an audio signal;

a microprocessor receiving the electrode inputs and the at least one microphone input, deriving therefrom an electrical systole QT and a mechanical systole QS2, calculating a QT/QS2 ratio; and

outputting the ratio as a diagnostic result.

19. The module of claim 18 further comprising a memory coupled to the microprocessor.

20. The module of claim 19 wherein the microprocessor derives the electrical and mechanical systoles by executing an algorithm stored in the memory.

21. The module of claim 19 wherein the microprocessor calculates the QT/QS2 ratio by executing an algorithm stored in the memory.

22. The module of claim 18 wherein the microprocessor calculates the QT/QS2 ratio from electrical and mechanical systoles derived from a common cardiac cycle.

23. A method for diagnosing LQTS in a patient, comprising:

measuring an electrical systole, QT, in the patient;

measuring a mechanical systole, QS2, in the patient;

calculating a QT/QS2 ratio; and

displaying a result of the QT/QS2 calculation.

24. The method of claim 23 wherein the electrical systole is measured using one or more electrodes.

25. The method of claim 23 wherein the mechanical systole is measured using one or more microphones.

26. The method of claim 23 further comprising simultaneously displaying a first waveform representing the electrical systole and a second waveform representing the mechanical systole.

27. The method of claim 26 further comprising synchronizing the first and second waveforms.

28. The method of claim 23 wherein the result comprises a number.

29. The method of claim 23 further comprising comparing the result to a predetermined threshold.

30. The method of claim 29 further comprising displaying a diagnosis based on the comparison.

31. The method of claim 23 further comprising measuring the electrical and mechanical systoles while the patient is in a state of rest.

32. The method of claim 31 further comprising repeating all steps while the patient is in a state of exercise.

33. The method of claim 23 further comprising measuring the electrical and mechanical systoles while the patient is in a state of exercise.

34. The method of claim 23 wherein the electrical systole comprises a time interval during one period of a cardiac cycle from onset of electrical depolarization of heart ventricles to end of electrical repolarization of the heart ventricles.

35. The method of claim 23 wherein the mechanical systole comprises a time interval during one period of a cardiac cycle from onset of electrical depolarization of heart ventricles to closure of a pulmonary valve.

36. The method of claim 23 wherein the measuring steps occur during a same cardiac cycle.

37. A method for evaluating the effectiveness of a drug for treating LQTS in a patient, comprising:

(a) measuring an electrical systole, QT, in the patient;

(b) measuring a mechanical systole, QS2, in the patient;

(c) calculating a QT/QS2 ratio;

(d) recording a result of the calculated QT/QS2 ratio;

administering a desired dose of the drug to the patient; and

repeating steps (a) through (d).

38. The method of claim 37 wherein QT and QS2 are measured during a same cardiac cycle.

39. A method for optimizing a dosage of a drug for treating LQTS in a patient, comprising:

(a) measuring an electrical systole, QT, in the patient;

(b) measuring a mechanical systole, QS2, in the patient;

(c) calculating a QT/QS2 ratio;

(d) recording a result of the calculated QT/QS2 ratio;

administering a dose of the drug to the patient;

repeating steps (a) through (d); and

comparing the recorded results to determine effectiveness of the dose.

40. The method of claim 39 wherein QT and QS2 are measured during a same cardiac cycle.

41. A method for evaluating whether a drug poses a risk of causing acquired LQTS in a patient, comprising:

(a) measuring an electrical systole, QT, in the patient;

(b) measuring a mechanical systole, QS2, in the patient;

(c) calculating a QT/QS2 ratio;

(d) recording a result of the calculated QT/QS2 ratio;

administering a dose of the drug to the patient;

repeating steps (a) through (d); and

comparing the recorded results.

42. The method of claim 41 wherein QT and QS2 are measured during a same cardiac cycle.